102 related articles for article (PubMed ID: 33818822)
1. Future outcomes and health needs of chronic hepatitis C patients after receiving antiviral therapy.
Hsiao YH; Chen WM; Chang CH; Chen MY
J Adv Nurs; 2021 Aug; 77(8):3370-3378. PubMed ID: 33818822
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of fatty liver and its association with metabolic syndrome among rural adults with chronic hepatitis C: Implications for primary healthcare.
Wang TJ; Chen MY; Lin YC; Chiu WN; Huang TJ; Weng HH
BMC Public Health; 2024 Feb; 24(1):532. PubMed ID: 38378519
[TBL] [Abstract][Full Text] [Related]
3. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal.
Lin YC; Chiu WN; Chang TS; Huang TJ; Chen MY
J Nurs Scholarsh; 2020 Mar; 52(2):128-135. PubMed ID: 31750620
[TBL] [Abstract][Full Text] [Related]
4. Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States.
Le TK; Macaulay D; Kalsekar A; Yuan Y; Sorg RA; Wei J; Wu EQ
Clin Ther; 2015 Aug; 37(8):1713-25.e3. PubMed ID: 26111918
[TBL] [Abstract][Full Text] [Related]
5. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
[TBL] [Abstract][Full Text] [Related]
6. Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting.
Dhiman RK; Grover GS; Premkumar M; Taneja S; Duseja A; Arora S; Rathi S; Satsangi S; Roy A;
J Hepatol; 2019 Dec; 71(6):1076-1085. PubMed ID: 31325468
[TBL] [Abstract][Full Text] [Related]
7. From self-care behaviours to cardiometabolic risks prevention for the health of farmers: Nursing implications.
Huang YT; Lin MS; James K; Chang CH; Tsai WH; Lin YC; Chen MY
J Adv Nurs; 2023 Aug; 79(8):3025-3034. PubMed ID: 36695405
[TBL] [Abstract][Full Text] [Related]
8. Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study.
Chang SC; Hung CT; Li SF; Lee HM; Chung YC; Pai LW; Yang SS
J Formos Med Assoc; 2015 Sep; 114(9):829-34. PubMed ID: 24090634
[TBL] [Abstract][Full Text] [Related]
9. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study.
Liu CH; Yu ML; Peng CY; Hsieh TY; Huang YH; Su WW; Cheng PN; Lin CL; Lo CC; Chen CY; Chen JJ; Ma Q; Brooks-Rooney C; Kao JH
J Formos Med Assoc; 2019 Jun; 118(6):1014-1023. PubMed ID: 30448077
[TBL] [Abstract][Full Text] [Related]
10. The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C.
Li Y; Zeng Y; Zeng G; Li J; Zhang X; Cai Q; Chen Y; Lin CS
J Med Virol; 2019 Feb; 91(2):278-286. PubMed ID: 30171691
[TBL] [Abstract][Full Text] [Related]
11. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach.
Li W; Chang TS; Chang SZ; Chen CH; Chen MY
BMC Infect Dis; 2020 Oct; 20(1):737. PubMed ID: 33028228
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
Su TH; Tseng TC; Liu CJ; Chou SW; Liu CH; Yang HC; Chen PJ; Chen DS; Chen CL; Kao JH
Int J Cancer; 2020 Aug; 147(3):901-908. PubMed ID: 31853972
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.
Su TH; Yang HC; Tseng TC; Chou SW; Lin CH; Liu CH; Liu CJ; Chen CL; Kao JH
Mov Disord; 2019 Dec; 34(12):1882-1890. PubMed ID: 31505068
[TBL] [Abstract][Full Text] [Related]
14. An Investigation of the Side Effects, Patient Feedback, and Physiological Changes Associated with Direct-Acting Antiviral Therapy for Hepatitis C.
Wu PS; Chang TS; Lu SN; Su HJ; Chang SZ; Hsu CW; Chen MY
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31817863
[No Abstract] [Full Text] [Related]
15. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
16. Misperception of cardiometabolic risks and health needs among agriculture and aquaculture workers in Taiwan.
Chen MY
Eur J Cardiovasc Nurs; 2021 May; 20(4):383-388. PubMed ID: 33620459
[TBL] [Abstract][Full Text] [Related]
17. The Role of e-Health in Optimizing Task-Shifting in the Delivery of Antiviral Therapy for Chronic Hepatitis C.
Yoo ER; Perumpail RB; Cholankeril G; Jayasekera CR; Ahmed A
Telemed J E Health; 2017 Oct; 23(10):870-873. PubMed ID: 28375820
[TBL] [Abstract][Full Text] [Related]
18. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
Bachofner JA; Valli PV; Kröger A; Bergamin I; Künzler P; Baserga A; Braun D; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens JC
Liver Int; 2017 Mar; 37(3):369-376. PubMed ID: 27678216
[TBL] [Abstract][Full Text] [Related]
19. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.
Söderholm J; Millbourn C; Büsch K; Kövamees J; Schvarcz R; Lindahl K; Bruchfeld A
J Hepatol; 2018 May; 68(5):904-911. PubMed ID: 29233630
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct-acting antiviral therapy of chronic hepatitis C.
Laursen TL; Siggaard CB; Kazankov K; Sandahl TD; Møller HJ; Tarp B; Kristensen LH; Laursen AL; Leutscher P; Grønbaek H
J Viral Hepat; 2020 Jan; 27(1):28-35. PubMed ID: 31502741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
